SYN, is displaying a off of a big move and has support at 2.30.
As highlighted on Bulkwoski's site (http://thepatternsite.com/dt.html): "If price rises into the pattern it breaks out upward 73% of the time."
This company 4 drugs ... one which has shown to improve MS patients, and another which address C Diff. C Diff has been declared by the CDC as in need of national focus. Shortly afterwards, C Diff caused Toronto's largest hospital to shut down a part of its cardiovascular unit. http://news.nationalpost.com/2015/02/11/torontos-largest-hospital-shuts-down-part-of-cardiovascular-unit-after-c-difficile-outbreak/. SYN is the only company to have a drug in the pipe that address C Diff.
This seeking alpha article does an excellent job summing up the potential in more depth for the pipeline.
This link from the SYN site, nicely sums up the pipeline:
Overall, this company is extremely undervalued and is primed for huge moves over the next several weeks as news of it's MS drug comes out.